Literature DB >> 2049076

Natural human interferon-alpha 2 is O-glycosylated.

G R Adolf1, I Kalsner, H Ahorn, I Maurer-Fogy, K Cantell.   

Abstract

Natural human interferon alpha 2 (IFN-alpha 2) was isolated from a preparation of partially purified human leucocyte IFN by monoclonal-antibody immunoaffinity chromatography. The purified protein had a specific activity of 1.5 x 10(8) i.u./mg; it was estimated to constitute 10-20% of the total antiviral activity of leucocyte IFN. N-Terminal amino-acid-sequence analysis identified the subspecies IFN-alpha 2b and/or IFN-alpha 2c, whereas IFN-alpha 2a was not detectable. The structure of natural IFN-alpha 2 was found to differ from that of its recombinant (Escherichia coli-derived) equivalent. First, reverse-phase h.p.l.c. showed that natural IFN-alpha 2 was significantly more hydrophilic then expected. Secondly, the apparent molecular mass of the natural protein determined by SDS/PAGE was higher than that of recombinant IFN-alpha 2; incubation under mild alkaline conditions known to eliminate O-linked carbohydrates resulted in a reduction of the apparent molecular mass to that of the recombinant protein. On sequence analysis of proteolytic peptides, Thr-106 was found to be modified. These results suggested that Thr-106 of natural IFN-alpha 2 carries O-linked carbohydrates. Reverse-phase h.p.l.c. as well as SDS/PAGE of natural IFN-alpha 2 showed that glycosylation is heterogeneous. For characterization of the carbohydrate moieties, the protein was treated with neuraminidase and/or O-glycanase and analysed by gel electrophoresis; in addition, glycopeptides obtained by proteinase digestion and separated by h.p.l.c. were characterized by sequence analysis and m.s. Further information on the composition of the glycans was obtained by monosaccharide analysis. The results indicate that natural IFN-alpha 2 contains the disaccharide galactosyl-N-acetylgalactosamine (Gal-GalNAc) linked to Thr-106. In part of the molecules, this core carbohydrate carries (alpha-)N-acetylneuraminic acid, whereas a disaccharide, probably N-acetyl-lactosamine, is bound to Gal-GalNAc in another proportion of the protein. Further glycosylation isomers are present in small amounts. As IFN-alpha 2 is the only IFN-alpha species with a threonine residue at position 106, it may represent the only O-glycosylated human IFN-alpha protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049076      PMCID: PMC1151121          DOI: 10.1042/bj2760511

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  Anti-interferon antibodies: a perspective.

Authors:  R A Figlin; L M Itri
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

2.  Amino-terminal amino acid sequence of human leukocyte interferon.

Authors:  W P Levy; J Shively; M Rubinstein; U Del Valle; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  A family of structural genes for human lymphoblastoid (leukocyte-type) interferon.

Authors:  G Allen; K H Fantes
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

4.  The structure of eight distinct cloned human leukocyte interferon cDNAs.

Authors:  D V Goeddel; D W Leung; T J Dull; M Gross; R M Lawn; R McCandliss; P H Seeburg; A Ullrich; E Yelverton; P W Gray
Journal:  Nature       Date:  1981-03-05       Impact factor: 49.962

5.  Human leukocyte interferon: isolation and characterization of several molecular forms.

Authors:  M Rubinstein; W P Levy; J A Moschera; C Y Lai; R D Hershberg; R T Bartlett; S Pestka
Journal:  Arch Biochem Biophys       Date:  1981-08       Impact factor: 4.013

6.  Amino acid sequence of a human leukocyte interferon.

Authors:  W P Levy; M Rubinstein; J Shively; U Del Valle; C Y Lai; J Moschera; L Brink; L Gerber; S Stein; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

7.  Amino terminal sequence of the major component of human lymphoblastoid interferon.

Authors:  K C Zoon; M E Smith; P J Bridgen; C B Anfinsen; M W Hunkapiller; L E Hood
Journal:  Science       Date:  1980-02-01       Impact factor: 47.728

8.  O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity.

Authors:  M Oh-eda; M Hasegawa; K Hattori; H Kuboniwa; T Kojima; T Orita; K Tomonou; T Yamazaki; N Ochi
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

9.  Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.

Authors:  P K Weck; S Apperson; L May; N Stebbing
Journal:  J Gen Virol       Date:  1981-11       Impact factor: 3.891

10.  At least three human type alpha interferons: structure of alpha 2.

Authors:  M Streuli; S Nagata; C Weissmann
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

View more
  18 in total

Review 1.  Structure-immunogenicity relationships of therapeutic proteins.

Authors:  Suzanne Hermeling; Daan J A Crommelin; Huub Schellekens; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

2.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  O-linked glycosylation leads to decreased thermal stability of interferon alpha 2b as measured by two orthogonal techniques.

Authors:  Michael James Wilson Johnston; Grant Frahm; Xuguang Li; Yves Durocher; Mary Alice Hefford
Journal:  Pharm Res       Date:  2011-03-09       Impact factor: 4.200

4.  Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.

Authors:  T A Nyman; H Tölö; J Parkkinen; N Kalkkinen
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

5.  Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry.

Authors:  Wen Zhou; Kristina Håkansson
Journal:  Curr Proteomics       Date:  2011-12-01       Impact factor: 0.837

6.  Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers.

Authors:  Edmund A Rossi; Diane L Rossi; Thomas M Cardillo; Rhona Stein; David M Goldenberg; Chien-Hsing Chang
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

Review 7.  Effects of localized interactions and surface properties on stability of protein-based therapeutics.

Authors:  Brittney J Mills; Jennifer S Laurence Chadwick
Journal:  J Pharm Pharmacol       Date:  2016-11-10       Impact factor: 3.765

8.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Periplasmic expression of human interferon-alpha 2c in Escherichia coli results in a correctly folded molecule.

Authors:  T Voss; E Falkner; H Ahorn; E Krystek; I Maurer-Fogy; G Bodo; R Hauptmann
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

10.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.